Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 4Sarcoma 2Breast 2Thoracic 1Gynecologic 1

Conditions

Uterine Cervical Neoplasms 1Urinary Retention 1

Interventions

Paclitaxel 268Carboplatin 264Cisplatin 194Bevacizumab 135pembrolizumab 99Surveys and Questionnaires 84Radiotherapy 77Cyclophosphamide 75olaparib 67Blood Specimen Collection 65Drug Therapy 62Hyperthermic Intraperitoneal Chemotherapy 60Gemcitabine 60niraparib 56Topotecan 56Brachytherapy 54liposomal doxorubicin 52Taxes 47Docetaxel 46Magnetic Resonance Spectroscopy 43Letrozole 36Cytoreduction Surgical Procedures 36Filgrastim 33Biopsy 33Surgical Procedures, Operative 32durvalumab 31Specimen Handling 31Doxorubicin 31Nivolumab 30Albumin-Bound Paclitaxel 28

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Donepezil × Gynecologic × Clear all
NCT05540977 2022-09-15

Donepezil Prevents Urinary Retention After Extensive Total Hysterectomy

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase EARLY_PHASE1 Unknown
108 enrolled
Gynecologic

Uterine Cervical Neoplasms, Urinary Retention

Data powered by HemOnc (CC BY 4.0) Colophon âš¡